Azenta (AZTA) Stock Rallies on Revenue Strength as Cash Burn Lingers

Azenta, Inc.

Azenta, Inc.

AZTA

0.00

Azenta walked into this earnings season with a turnaround label and a stock that had already climbed over the past quarter. The 5.6% jump to US$31.82 after the Q3 print shows investors liked what they saw. The tension is simple: the company still reports losses on a trailing basis, yet this quarter delivered US$161.2m of revenue and positive non GAAP earnings per share of US$0.16. That mix of improving income metrics and ongoing red ink is the real story behind today’s upbeat price reaction.

Love Azenta's move to positive non GAAP earnings per share, but still cautious about the trailing losses and volatility that can come with a turnaround story? Check out 79 resilient stocks with low risk scores to benchmark Azenta against companies that pair steadier financial profiles with lower risk scores.

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs Q3 2025): US$161.2m vs. US$143.9m (higher year over year)
  • Net Income or Loss, Excluding Extra Items (Q3 2026 vs Q3 2025): loss of US$1.5m vs. profit of US$0.7m (moved back into loss)
  • Basic EPS (Q3 2026 vs Q3 2025): loss of US$0.03 per share vs. profit of US$0.01 per share (swing back to a loss per share)
  • Earnings from Discontinued Operations (Q3 2026 vs Q3 2025): profit of US$4.0m vs. loss of US$53.5m (shift to positive contribution from discontinued operations)

Prefer clean charts instead of another wall of earnings tables and footnotes? Get a full visual picture of Azenta with an at-a-glance view of its valuation profile in the company report for Azenta.

NasdaqGS:AZTA Trailing 12-Month Earnings & Revenue History as at Aug 2026
NasdaqGS:AZTA Trailing 12-Month Earnings & Revenue History as at Aug 2026

Evaluating Whether Azenta’s Turnaround Is Taking Hold

Bulls argue that Azenta can convert industry tailwinds and internal efficiency work into steadier recurring revenue and better margins. This quarter moves that story forward but does not fully seal it. Revenue grew 12% with 9% organic growth, above the preview that framed a modest 3.7% gain as the hurdle. That suggests the refreshed commercial push and stronger demand in Europe and China are starting to show up in the top line.

The thesis also leans heavily on margin recovery from the Azenta Business System and Kaizen programs. Adjusted EBITDA margin of about 11.4% improved sequentially, yet it was slightly lower than a year ago and free cash flow was still a US$5m outflow. Quality remediation spend is shrinking and largely complete, which supports the idea that automated store issues are closer to contained. Overall, Azenta hit several early milestones, but the profitability leg of the bull case remains only partially proven.

Access the full street playbook on where the calm surface might crack and when the models start to disagree on Azenta's multi year path by reviewing the analyst estimates for Azenta.

Azenta Bear Case: Margin Drag and Cash Flow Still Bite

Bears argue that Azenta’s quality issues, regional mix and lab inefficiencies keep margins and cash generation stuck, even with healthy demand. This quarter does not fully clear that bar. Automated store remediation is “largely complete,” yet adjusted EBITDA margin sits around 11.4% and is slightly lower than a year ago. That keeps the narrative of slower margin recovery intact. Free cash flow stayed negative at about US$5m, which aligns with concerns that earnings are not yet translating into cash.

The bearish view also flags Asia growth coming at lower margin and ongoing Sanger sequencing pressure. Management highlights China and Europe strength and calls Sanger a continued headwind, which fits that story. Guidance for full year organic revenue of flat to up 1% and an expected low single digit decline in Q4 organic revenue shows progress versus earlier cuts, but it still suggests the turnaround timeline on growth and margin is stretched rather than resolved.

With Azenta still reporting trailing losses, negative free cash flow and a market price above the DCF figure, it is worth stress testing the balance sheet. Check whether the turnaround has enough funding strength in our financial health analysis of Azenta stock.

Stay Ahead With Simply Wall St

If Azenta’s mix of improving revenue and ongoing losses has your attention, register for free with Simply Wall St and add it to your Watchlist to track price moves against fair value and watch how the turnaround story develops. Once you decide to take a position, use the Portfolio Command Center to cut through market noise and focus on the key updates that matter for your holdings. For a wider view on what other investors are seeing and questioning, tap into the Community and compare perspectives. By spotting potential catalysts and risks early, you give yourself a better chance to react fast and stay ahead of the market.

Seeking Alternatives Beyond Azenta Stock

Fresh stock ideas can start gaining breakout momentum before most investors even notice. Use these under the radar for now lists while it matters and get in early.

  • Scan for potential early breakout stories with proven business strength by reviewing the curated 17 high quality undiscovered gems before other investors get caught chasing moves already in full flight.
  • Spot potential long run compounders with resilient finances by checking the hand picked list of solid balance sheet and fundamentals stocks (50 results) while valuations may still reward those who move before the crowd.
  • Focus on companies where income drives total return potential by using the carefully filtered 8 dividend fortresses while yields and share prices still look aligned for patient investors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.